Japan to purchase 150M doses of Novavax's COVID-19 vaccine

99
13
Favorite

Japan to purchase 150M doses of Novavax's COVID-19 vaccine

seekingalpha2021-09-07

(Update: Sept 7 2021 at 04:31 a.m. ET) The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters. The company's Japanese partner, Takeda Pharmaceutical...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（13）

A68
·2021-09-08
Ok
Reply
1
Report
Annie_ann29
·2021-09-07
Like plz
Reply
1
Report
Dcagency
·2021-09-07
$$$$$$
Reply
2
Report
Fold Replies
- MIe:
  Novavax non MRNA revenue Upside#
  2021-09-07
  Reply
  Report
lewisleeks
·2021-09-07
[Miser] [Miser]
Reply
3
Report
Fold Replies
- ZacN:
  Ok
  2021-09-07
  Reply
  Report
PhilipLoo
·2021-09-07
Wow good news
Reply
5
Report
RO8
·2021-09-07
Higher up please.
Reply
6
Report
Fold Replies
- Annie_ann29:
  
  Like
  2021-09-07
  Reply
  Report
YCLim
·2021-09-07
Wow nice
Reply
9
Report
Fold Replies
- JKGan:
  ok
  2021-09-09
  Reply
  Report
Zx1008
·2021-09-07
Nice
Reply
7
Report
Fold Replies
- Kazmir:
  nice
  2021-09-07
  Reply
  Report
Kelvink73
·2021-09-07
Another Vaccine to be approved. Hope it will be more effective.
Reply
7
Report
Fold Replies
- DonOng:
  agree
  2021-09-07
  Reply
  Report
LongZR
·2021-09-07
Nice
Reply
4
Report
Fold Replies
- LongZR:
  nice
  2021-09-07
  Reply
  Report
Yappydappy
·2021-09-07
Does this mean stock price will go up?
Reply
5
Report
stingray102
·2021-09-07
Ok
Reply
5
Report
Fold Replies
- xiaoxiami:
  ok
  2021-09-07
  Reply
  Report
Blackk
·2021-09-07
Yup
Reply
5
Report
Fold Replies
- Babypegasus:
  Like and comment !
  2021-09-07
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1170186591?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-09-07 15:47","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1170186591","market":"us","top_or_hot":-1,"title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","media":"seekingalpha","content":"<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","article_id":"1170186591","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","pubTimestamp":1631000826,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"日本将购买1.5亿剂诺瓦瓦克斯医药新冠肺炎疫苗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":0.9},"content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":880565452,"gmtCreate":1631066198776,"gmtModify":1676530457448,"author":{"id":"3576813955258325","authorId":"3576813955258325","name":"A68","avatar":"https://static.tigerbbs.com/d209afa981c29a4dc34bd7c1c986fb4a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576813955258325","idStr":"3576813955258325"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880565452","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":880119719,"gmtCreate":1631024574231,"gmtModify":1676530446283,"author":{"id":"4088678216292640","authorId":"4088678216292640","name":"Annie_ann29","avatar":"https://static.tigerbbs.com/74b75bf973f051fd1f70b054cc66a45c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"4088678216292640","idStr":"4088678216292640"},"htmlText":"Like plz","listText":"Like plz","text":"Like plz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880119719","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":880103893,"gmtCreate":1631023237212,"gmtModify":1676530445583,"author":{"id":"3557142354281361","authorId":"3557142354281361","name":"Dcagency","avatar":"https://static.tigerbbs.com/811d507c3458decd0eacd9028472dcf4","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3557142354281361","idStr":"3557142354281361"},"htmlText":"$$$$$$&nbsp;","listText":"$$$$$$&nbsp;","text":"$$$$$$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880103893","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5782328,"gmtCreate":1631024517367,"gmtModify":1663233514835,"authorId":3577182936341023,"author":{"id":3577182936341023,"idStr":"3577182936341023","authorId":3577182936341023,"name":"MIe","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.11","exceedPercentage":"93.90%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880103893,"type":1,"supId":0,"prevId":0,"content":"Novavax non MRNA revenue Upside#","text":"Novavax non MRNA revenue Upside#","html":"Novavax non MRNA revenue Upside#"}],"langContent":"EN"},{"id":880989868,"gmtCreate":1631009021154,"gmtModify":1676530441156,"author":{"id":"4089010444435920","authorId":"4089010444435920","name":"lewisleeks","avatar":"https://static.tigerbbs.com/d39cf835a09bdd21dce8a780b993940c","vip":1,"crmLevel":1,"crmLevelSwitch":1,"authorIdStr":"4089010444435920","idStr":"4089010444435920"},"htmlText":"[Miser]&nbsp;[Miser]&nbsp;","listText":"[Miser]&nbsp;[Miser]&nbsp;","text":"[Miser] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880989868","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5781687,"gmtCreate":1631022098799,"gmtModify":1663233514560,"authorId":3577220211671569,"author":{"id":3577220211671569,"idStr":"3577220211671569","authorId":3577220211671569,"name":"ZacN","avatar":"https://static.tigerbbs.com/4b39e21f419b5bf9c135c152e2e2b227","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.22","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880989868,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"},{"id":880907151,"gmtCreate":1631005495773,"gmtModify":1676530440282,"author":{"id":"4087194995399330","authorId":"4087194995399330","name":"PhilipLoo","avatar":"https://community-static.tradeup.com/news/5524c7dd0d4c13480fd65b9cd3fba52d","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"4087194995399330","idStr":"4087194995399330"},"htmlText":"Wow good news","listText":"Wow good news","text":"Wow good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880907151","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":880071606,"gmtCreate":1631004118305,"gmtModify":1676530439839,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585981947031986","idStr":"3585981947031986"},"htmlText":"Higher up please.&nbsp;","listText":"Higher up please.&nbsp;","text":"Higher up please.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880071606","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5782342,"gmtCreate":1631024590506,"gmtModify":1663233520138,"authorId":4088678216292640,"author":{"id":4088678216292640,"idStr":"4088678216292640","authorId":4088678216292640,"name":"Annie_ann29","avatar":"https://static.tigerbbs.com/74b75bf973f051fd1f70b054cc66a45c","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880071606,"type":1,"supId":0,"prevId":0,"content":"<br>\n<br>Like","text":"<br>\n<br>Like","html":"<br>\n<br>Like"}],"langContent":"EN"},{"id":880073862,"gmtCreate":1631004054056,"gmtModify":1676530439813,"author":{"id":"3570854002442844","authorId":"3570854002442844","name":"YCLim","avatar":"https://community-static.tradeup.com/news/f8f1fe40879e998d6b05894eec399e51","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3570854002442844","idStr":"3570854002442844"},"htmlText":"Wow nice","listText":"Wow nice","text":"Wow nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880073862","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5797859,"gmtCreate":1631141963016,"gmtModify":1663233578275,"authorId":3577494759333904,"author":{"id":3577494759333904,"idStr":"3577494759333904","authorId":3577494759333904,"name":"JKGan","avatar":"https://static.tigerbbs.com/918b0f86622cedc2f23e00ebe3ce6924","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.65%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880073862,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":880079667,"gmtCreate":1631004026459,"gmtModify":1676530439789,"author":{"id":"3581823706139517","authorId":"3581823706139517","name":"Zx1008","avatar":"https://static.tigerbbs.com/fdb3cce08a739e317d4fb462983c1cee","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3581823706139517","idStr":"3581823706139517"},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880079667","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5779838,"gmtCreate":1631006490805,"gmtModify":1631889150663,"authorId":3558609398993628,"author":{"id":3558609398993628,"idStr":"3558609398993628","authorId":3558609398993628,"name":"Kazmir","avatar":"https://static.tigerbbs.com/6fbf34248b52f1c38a9dc30ae20b49d8","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880079667,"type":1,"supId":0,"prevId":0,"content":"<u>nice</u>","text":"<u>nice</u>","html":"<u>nice</u>"}],"langContent":"EN"},{"id":880051422,"gmtCreate":1631002712466,"gmtModify":1676530439386,"author":{"id":"3586752204475642","authorId":"3586752204475642","name":"Kelvink73","avatar":"https://static.tigerbbs.com/8c719c2e9dfb696800beef6e2afa018a","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3586752204475642","idStr":"3586752204475642"},"htmlText":"&nbsp;Another Vaccine to be approved. Hope it will be more effective.","listText":"&nbsp;Another Vaccine to be approved. Hope it will be more effective.","text":"Another Vaccine to be approved. Hope it will be more effective.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880051422","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5779066,"gmtCreate":1631002754899,"gmtModify":1663233503942,"authorId":3584847656643563,"author":{"id":3584847656643563,"idStr":"3584847656643563","authorId":3584847656643563,"name":"DonOng","avatar":"https://static.tigerbbs.com/54759d027c86613457f9642d36d1623a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880051422,"type":1,"supId":0,"prevId":0,"content":"<u>agree</u>","text":"<u>agree</u>","html":"<u>agree</u>"}],"langContent":"EN"},{"id":880051042,"gmtCreate":1631002665286,"gmtModify":1676530439378,"author":{"id":"3572305441240915","authorId":"3572305441240915","name":"LongZR","avatar":"https://static.tigerbbs.com/80b6c7bb6866455f69d500fddb520c7e","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3572305441240915","idStr":"3572305441240915"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880051042","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5779044,"gmtCreate":1631002671655,"gmtModify":1663233503039,"authorId":3572305441240915,"author":{"id":3572305441240915,"idStr":"3572305441240915","authorId":3572305441240915,"name":"LongZR","avatar":"https://static.tigerbbs.com/80b6c7bb6866455f69d500fddb520c7e","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880051042,"type":1,"supId":0,"prevId":0,"content":"nice","text":"nice","html":"nice"}],"langContent":"EN"},{"id":880050319,"gmtCreate":1631002554731,"gmtModify":1676530439313,"author":{"id":"3579410204959880","authorId":"3579410204959880","name":"Yappydappy","avatar":"https://static.tigerbbs.com/5b6252f503d56d09093797f9e318ebf9","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3579410204959880","idStr":"3579410204959880"},"htmlText":"Does this mean stock price will go up?&nbsp;","listText":"Does this mean stock price will go up?&nbsp;","text":"Does this mean stock price will go up?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880050319","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":880062214,"gmtCreate":1631001411738,"gmtModify":1676530438964,"author":{"id":"3559604919356928","authorId":"3559604919356928","name":"stingray102","avatar":"https://static.tigerbbs.com/547c93575fd0fd499d515ad2092a2e9d","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3559604919356928","idStr":"3559604919356928"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880062214","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5778984,"gmtCreate":1631002390273,"gmtModify":1663233503634,"authorId":3585182376526952,"author":{"id":3585182376526952,"idStr":"3585182376526952","authorId":3585182376526952,"name":"xiaoxiami","avatar":"https://static.tigerbbs.com/16e6d77d95ad36c90962b4bd75fa83d6","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880062214,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":880066425,"gmtCreate":1631001302167,"gmtModify":1676530438937,"author":{"id":"3572770726668540","authorId":"3572770726668540","name":"Blackk","avatar":"https://static.tigerbbs.com/93d9bfa23cdea8af3308e34dedf35d9e","vip":1,"crmLevel":9,"crmLevelSwitch":0,"authorIdStr":"3572770726668540","idStr":"3572770726668540"},"htmlText":"Yup","listText":"Yup","text":"Yup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880066425","repostId":1170186591,"repostType":4,"repost":{"id":"1170186591","kind":"news","pubTimestamp":1631000826,"share":"https://ttm.financial/m/news/1170186591?lang=&edition=fundamental","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5779002,"gmtCreate":1631002489805,"gmtModify":1663233504737,"authorId":3583893737218100,"author":{"id":3583893737218100,"idStr":"3583893737218100","authorId":3583893737218100,"name":"Babypegasus","avatar":"https://static.tigerbbs.com/31f55e881f0d486b542cce91a4a8d8be","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":880066425,"type":1,"supId":0,"prevId":0,"content":"Like and comment ! ","text":"Like and comment ! ","html":"Like and comment ! "}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":99,"commentSize":13,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}